Abstract
Introduction
Complement deficiencies are rare primary immunodeficiency disorders, the diagnosis of which is often underestimated. Only a small number of molecular studies have been carried out for the characterization of the underlying genetic defects in these cases.
Purpose
Reporting the first family from the Arabian Gulf region with multiple members affected by meningococcemia and abscent serum complement 5 (C5). We tried to correlate clinical, biochemical and molecular genetics features of this family.
Methods
Determination of the serum level of all complement proteins including the terminal cascade (C5-9), followed by mutation analysis on DNA extracted from fresh blood samples of each alive family member.
Results
Molecular studies showed a homozygous nonsense mutation in exon 1, with the change of cytosine to thymine at position 55 (55C > T) leading to change of the glutamine amino acid at position 19 to a stop codon (Q19X), and serologically absence of C5 in the serum. A similar but compound heterozygous mutation has been reported in one African–American family. previously.
Conclusion
Characterization of the underlying mutations in C5 deficient families is important, to understand this uncommon complement deficiency, and try to elucidate structure–function relationships in the C5 gene. This report also highlights the importance of complement screening in cases of sporadic meningococcal Infections, especially in communities with high prevalence of consanguineous marriages, which will ensure timely and adequate clinical interventions.
References
Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359–95.
Miller ME, Nilsson UR. A familial deficiency of the phagocytosis-enhancing activity serum related to a dysfunction of the fifth component of complement(C5) N. Engl J Med. 1970;282(7):354–35.
Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Med (Baltimore). 1984;63:243–73.
Carney DF, Haviland DL, Noack D, Wetsel RA, Vik DP, Tack BF. Structural aspects of the human C5 gene. Intron/exon organization, 5_ flanking region features, and characterization of two truncated cDNA clones. J Biol Chem. 1991;266:18786–91.
Ware CF, Kolb WP. Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers. Proc Natl Acad Sci U S A. 1981;78(10):6426–30.
Haeney M, Ball A, Thompson R. Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6). Immunobiology. 1980;158(1–2):101–6.
Haviland DL, Haviland JC, Fleischer DT, Hunt A, Westel RA. Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gen. J Immunol. 1991;146:362–8.
Peter G, Weigert MB, Bissel AR, Gold R, Kreutzer D, Mclean RH. Meningoccocal meningitis in familial deficiency of the fifth component of complement. Pediatrics. 1981;67:882–6.
Delgado-Cerviño E, Fontan G, Lopez-Trascasa M. C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect. Mol Immunol. 2005;42(1):105–11.
Aguilar-Ramirez P, Reis ES, Florido MP, Barbosa AS, Farah CS, Costa-Carvalho BT. Isaac L Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability. Mol Immunol. 2009;46(10):2116–23.
Zerzri Y, Kallel-Sellami M, Abdelmalek R, Laadhar L, Ben Chaabane T, Makni S. Hereditary complement C5 deficiency: study of 3 Tunisian adult cases and literature review. Tunis Med. 2010;88(4):269–76.
Wang X, Fleischer DJ, Whitehead WT, Haviland DL, Rosenfeld SI, Leddy JP, et al. Inherited human complement C5 deficiency in three African–American families. J Immunol. 1995;154(10):5464–71.
Snyderman R, Durack DT, McCarty GA, Ward FE, Meadows L. Deficiencyof the fifth complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med. 1979;67(4):638–45.
López-Lera A, Garrido S, de la Cruz RM, Fontán G, López-Trascasa M. Molecular characterization of three new mutations causing C5 deficiency in two non-related families. Mol Immunol. 2009;46(11–12):2340–7.
Greisenegger S, Zehetmayer S, Bauer P, Endler G, Ferrari J, Lang W, et al. Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. Clin Chem. 2009;55(1):134–8.
Sanal O, Loos M, Ersoy F, Kanra G, Secmeer G, Tezcan I. Complement component deficiencies and infection: C5 C8 and C3 deficiencies in three families. Eur J Pediatr. 1992;151(9):676–9.
Pfarr N, Prawitt D, Kirschfink M, Schroff C, Knuf M, Habermehl P, et al. Linking C5 deficiency to an exonic, splicing enhancer mutation. J Immunol. 2005;174(7):4172–7.
Grimnes G, Beckman H, Lappegård KT, Mollnes TE, Skogen V. Recurrent meningococcal sepsis in presumptive immunocompetent host shown to be complement C5 deficient—a case report. APMIS. 2011;119:479–84.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Arnaout, R., Al Shorbaghi, S., Al Dhekri, H. et al. C5 Complement Deficiency in a Saudi Family, Molecular Characterization of Mutation and Literature Review. J Clin Immunol 33, 871–875 (2013). https://doi.org/10.1007/s10875-013-9872-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-013-9872-7